YU56698A - UPOTREBA INHIBITORA H*,K*-ATPaze ZA PRIOZVODNJU NOVIH FARMACEUTSKIH PREPARATA - Google Patents

UPOTREBA INHIBITORA H*,K*-ATPaze ZA PRIOZVODNJU NOVIH FARMACEUTSKIH PREPARATA

Info

Publication number
YU56698A
YU56698A YU56698A YU56698A YU56698A YU 56698 A YU56698 A YU 56698A YU 56698 A YU56698 A YU 56698A YU 56698 A YU56698 A YU 56698A YU 56698 A YU56698 A YU 56698A
Authority
YU
Yugoslavia
Prior art keywords
inhibitor
atpaze
production
pharmaceutical preparations
new pharmaceutical
Prior art date
Application number
YU56698A
Other languages
English (en)
Inventor
Christer Cederberg
George Sachs
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of YU56698A publication Critical patent/YU56698A/sh
Publication of RS49590B publication Critical patent/RS49590B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

Novi režim ordiniranja koji daje produženi profil koncentracije inhibitora H+,K+-ATP-aze u plazmi. Produženi profil u plazmi se dobija administriranjem dve ili više jediničnih doza inhibotora H+,K+-ATPaze sa vremenskim intervalom 0,5 do 4 sata, ili farmaceutskim preparatom sa produženim oslobadjanjem, koji se može ordinirati jedanput na dan.[New way of application that gives prolonged profile of concentracion of H+,K+-ATP-aze inhibitors in plasma. Prolonged profile in plasma is obtained by administration of two or more single dosages of H+,K+-ATP-aze inhibitor with lapse of time 0,5 up to 4 hours, or pharmaceutical preparation with prolonged release, that can be in application once a day.
YUP-566/98A 1996-06-20 1998-12-09 Upotreba inhibitora h+,k+-atpaze za proizvodnju novih farmaceutskih preparata RS49590B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9602442A SE9602442D0 (sv) 1996-06-20 1996-06-20 Administration of pharmaceuticals

Publications (2)

Publication Number Publication Date
YU56698A true YU56698A (sh) 2004-12-31
RS49590B RS49590B (sr) 2007-06-04

Family

ID=20403092

Country Status (28)

Country Link
US (4) US20010008900A1 (sh)
EP (1) EP0921787B1 (sh)
JP (1) JP2000512993A (sh)
CN (1) CN1178648C (sh)
AT (1) ATE252885T1 (sh)
AU (1) AU726859B2 (sh)
BR (1) BR9709838A (sh)
CA (1) CA2257405A1 (sh)
CZ (1) CZ298213B6 (sh)
DE (1) DE69725860T2 (sh)
DK (1) DK0921787T3 (sh)
EE (1) EE04606B1 (sh)
ES (1) ES2208921T3 (sh)
HK (1) HK1018590A1 (sh)
HU (1) HUP9901794A3 (sh)
IL (2) IL127542A0 (sh)
IS (1) IS2216B (sh)
NO (1) NO323295B1 (sh)
NZ (1) NZ332990A (sh)
PL (1) PL189716B1 (sh)
PT (1) PT921787E (sh)
RS (1) RS49590B (sh)
RU (1) RU2203662C2 (sh)
SE (1) SE9602442D0 (sh)
SK (1) SK284204B6 (sh)
TR (1) TR199802647T2 (sh)
UA (1) UA64715C2 (sh)
WO (1) WO1997048380A1 (sh)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5945124A (en) * 1995-07-05 1999-08-31 Byk Gulden Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
GB9720061D0 (en) 1997-09-19 1997-11-19 Crosfield Joseph & Sons Metal compounds as phosphate binders
SE9704870D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulation I
SE9704869D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulaton II
WO1999055157A1 (en) * 1998-04-30 1999-11-04 Sepracor Inc. R-rabeprazole compositions and methods
AU3967399A (en) * 1998-04-30 1999-11-16 Sepracor, Inc. S-rabeprazole compositions and methods
BR9912937A (pt) 1998-08-10 2001-05-08 Partnership Of Michael E Garst Pró-drogas de inibidores de bomba de prótons
US6093734A (en) * 1998-08-10 2000-07-25 Partnership Of Michael E. Garst, George Sachs, And Jai Moo Shin Prodrugs of proton pump inhibitors
ATE321538T1 (de) 1998-08-12 2006-04-15 Altana Pharma Ag Orale darreichungsform für pyridin-2- ylmethylsulfinyl-1h-benzimidazole
US20050048077A1 (en) * 2002-02-21 2005-03-03 George Sachs Compositions, test kits and methods for detecting helicobacter pylori
MY148805A (en) * 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
TWI372066B (en) 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
JP5563735B2 (ja) 2004-06-16 2014-07-30 タケダ ファーマシューティカルズ ユー．エス．エー． インコーポレイティド Ｐｐｉ多回剤形
MY157620A (en) 2006-01-31 2016-06-30 Cytochroma Dev Inc A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
GB0714670D0 (en) 2007-07-27 2007-09-05 Ineos Healthcare Ltd Use
GB0720220D0 (en) 2007-10-16 2007-11-28 Ineos Healthcare Ltd Compound
GB0913525D0 (en) 2009-08-03 2009-09-16 Ineos Healthcare Ltd Method
GB201001779D0 (en) 2010-02-04 2010-03-24 Ineos Healthcare Ltd Composition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2189699A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
US5330982A (en) * 1986-12-17 1994-07-19 Glaxo Group Limited Pharmaceutical composition containing a 5-HT receptor antagonist and an H+ K+ Atpase inhibitor and a method of treating gastrointestingal disorders therewith
EP0695123A4 (en) * 1993-04-27 1996-09-11 Sepracor Inc METHOD AND COMPOSITIONS FOR TREATING GASTRICAL FAULTS USING OPTICALLY PURE PANTOPRAZOLS
PT1078628E (pt) * 1994-07-08 2009-01-27 Astrazeneca Ab Forma de dosagem em comprimidos com unidades múltiplas
SE9402431D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New tablet formulation
US6132768A (en) * 1995-07-05 2000-10-17 Byk Gulden Lomberg Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for reversible proton pump inhibitors
US5945124A (en) * 1995-07-05 1999-08-31 Byk Gulden Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole

Also Published As

Publication number Publication date
HK1018590A1 (en) 1999-12-30
SK165598A3 (en) 1999-08-06
CN1178648C (zh) 2004-12-08
US20090036494A1 (en) 2009-02-05
US20010008900A1 (en) 2001-07-19
PT921787E (pt) 2004-03-31
AU726859B2 (en) 2000-11-23
EE04606B1 (et) 2006-04-17
NO985964L (no) 1999-02-22
BR9709838A (pt) 1999-08-10
US20050113418A1 (en) 2005-05-26
IS2216B (is) 2007-03-15
SE9602442D0 (sv) 1996-06-20
ATE252885T1 (de) 2003-11-15
CZ298213B6 (cs) 2007-07-25
CA2257405A1 (en) 1997-12-24
RU2203662C2 (ru) 2003-05-10
DE69725860T2 (de) 2004-09-09
CZ420398A3 (cs) 2000-02-16
IL127542A0 (en) 1999-10-28
TR199802647T2 (xx) 1999-03-22
DE69725860D1 (de) 2003-12-04
RS49590B (sr) 2007-06-04
US20070276007A1 (en) 2007-11-29
DK0921787T3 (da) 2004-02-23
ES2208921T3 (es) 2004-06-16
SK284204B6 (sk) 2004-10-05
AU3469097A (en) 1998-01-07
PL189716B1 (pl) 2005-09-30
HUP9901794A3 (en) 2002-11-28
PL330910A1 (en) 1999-06-07
IS4923A (is) 1998-12-15
NO323295B1 (no) 2007-03-05
CN1222074A (zh) 1999-07-07
EP0921787B1 (en) 2003-10-29
NZ332990A (en) 2000-07-28
WO1997048380A1 (en) 1997-12-24
UA64715C2 (en) 2004-03-15
EP0921787A1 (en) 1999-06-16
IL127542A (en) 2006-08-01
HUP9901794A2 (hu) 2000-04-28
EE9800435A (et) 1999-06-15
JP2000512993A (ja) 2000-10-03
NO985964D0 (no) 1998-12-18

Similar Documents

Publication Publication Date Title
YU56698A (sh) UPOTREBA INHIBITORA H*,K*-ATPaze ZA PRIOZVODNJU NOVIH FARMACEUTSKIH PREPARATA
SE9704870D0 (sv) New pharmaceutical formulation I
NO20005566D0 (no) FremgangsmÕter ved anvendelse av preparater med konjugert linolsyre anriket med isomerer
GEP20032998B (en) Substituted Benzenesulfonamide Derivatives as Prodrugs of Cox-2 Inhibitors
CA2105575A1 (en) Esters of bi- and tricyclic amino alcohols, their preparation and their use in pharmaceutical compositions
TW352384B (en) Sulfonamido- or sulfonamidocarbonylpyridine-2-carboxamides, process for their preparation and their use as pharmaceuticals
GEP20053510B (en) Substituted Pyrrolopyridinone Derivatives Useful as Phosphodiesterase Inhibitors
EP0735819A4 (en) NEW CRYPTOPHYCINE
EP1026157A3 (en) Method for the synthesis of huperzine A and analogs thereof and compounds useful therein
MY117090A (en) Substituted benzamidines, their preparation and their use as pharmaceutical compounds
EP0664128A4 (en) PHARMACEUTICAL AGENT FOR INHIBITING TUMORNESCROSE FACTOR PRODUCTION.
NO953763L (no) Heterocykel-holdige amidin-derivater, deres fremstilling og anvendelse
AU2001260540A1 (en) Extracts from spermatophyte plants with antitumor activity
GEP20053617B (en) Bridged Piperazine Derivatives
HRP20030002A2 (en) STABLE GABAPENTIN HAVING pH WITHIN A CONTROLLED RANGE
MX9700245A (es) Nuevo compuesto quimico, su preparacion y su empleo como medicamento.
AU2420001A (en) Methods and compositions for the treatment of pain
GEP20032968B (en) Use of Ketolides in Pharmaceutical Compositions for Preventing Thrombotic Arterial Complications Linked to Atherosclerosis
AU3903701A (en) Diclofenac pharmaceutical composition based on vitamin-e, papain and hyaluronidase
ID19401A (id) N-sianoimina trisiklik baru yang berguna sebagai inhibitor farnesil-protein transferase
MX9804798A (es) Nuevos compuestos con efecto analgesico.
IT8409529A0 (it) Utilizzazione terapeutica di formulazioni farmaceutiche costituite da associazioni di corticosteroidi analoghe a quelle prodotte dalla ghiandola surrenale umana, e prodotto farmaceutico relativo
UA31688A (uk) Спосіб лікування хронічного рецидивного афтозного стоматиту у дітей